Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

CD15

CD15 A variety of antibodies detect the antigen defined by the cluster designation group 15 (CD15). These antibodies have been reported to be helpful in the diagnosis of many different diseases including leukemia, Hodgkin's disease, and non-Hodgkin's lymphoma, as well as aiding in the differential diagnosis between epithelial malignant mesothelioma and adenocarcinoma. In this review we describe the immunoreactivity of many of the CD15 antibodies, including MMA (Leu M1), anti-My1, C3D-1 (Dako-M1), VIM-D5, 1G10, MCS-1, anti-SSEA, and 3C4. The expression of the CD15 antigen in non-neoplastic human cells, leukemic cell lines and in neoplastic cells is reviewed. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied Immunohistochemistry & Molecular Morphology Wolters Kluwer Health

Loading next page...
 
/lp/wolters-kluwer-health/cd15-YnDT6WuZkS

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1062-3345
eISSN
1533-4058

Abstract

A variety of antibodies detect the antigen defined by the cluster designation group 15 (CD15). These antibodies have been reported to be helpful in the diagnosis of many different diseases including leukemia, Hodgkin's disease, and non-Hodgkin's lymphoma, as well as aiding in the differential diagnosis between epithelial malignant mesothelioma and adenocarcinoma. In this review we describe the immunoreactivity of many of the CD15 antibodies, including MMA (Leu M1), anti-My1, C3D-1 (Dako-M1), VIM-D5, 1G10, MCS-1, anti-SSEA, and 3C4. The expression of the CD15 antigen in non-neoplastic human cells, leukemic cell lines and in neoplastic cells is reviewed.

Journal

Applied Immunohistochemistry & Molecular MorphologyWolters Kluwer Health

Published: Jan 1, 1993

There are no references for this article.